Skip to main content
Top
Published in: Journal of Gastrointestinal Cancer 2/2017

01-06-2017 | Original Research

Time to Progression of Pancreatic Cancer: Evaluation with Multi-Detector Computed Tomography

Authors: Su Joa Ahn, Seung Joon Choi, Hyung Sik Kim

Published in: Journal of Gastrointestinal Cancer | Issue 2/2017

Login to get access

Abstract

Purpose

The aim of this study is to evaluate the natural history of untreated pancreatic cancer, with a particular emphasis on the growth rate of primary tumor and development of metastatic disease.

Methods

One hundred patients with histologically proven pancreatic ductal adenocarcinoma examined with at least two CT scans with no intervening treatment were included. Tumor diameters and volumes were measured in CT scans and tumor growth rates and volume doubling times (VDTs) were calculated. The relationship between initial tumor size, growth rate, and distant metastasis development were investigated.

Results

Included tumors were 1.0–6.2 cm (mean, 2.9 ± 1.3 cm) in diameter and 5.5–1225.9 cm3 (mean, 120.6 ± 158.9 cm3) in volume at the initial CT. Tumor growth rates were −0.4 to 19.9 cm/year (mean, 4.2 ± 3.8 cm/year) in diameter, and 11.1–13,321.5 cm3/year (mean, 727.8 ± 1609.5 cm3/year) in volume corresponding to VDT of 20.0–976.8 days (mean, 132.3 ± 132.1 days). The growth rate was significantly associated with the initial diameter and volume (p < 0.001). The development of distant metastasis was significantly associated with initial diameter (p < 0.05), volume (p = 0.015), and volume growth rate (p = 0.002).

Conclusions

The growth rate and VDTs of untreated pancreatic cancers varied widely, from less than a month to more than 4 years, positively associated with tumor size. The small tumors tend to grow slowly and have low risk for developing metastasis.
Literature
1.
go back to reference Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74–108.CrossRefPubMed Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74–108.CrossRefPubMed
4.
go back to reference Matsuno S, Egawa S, Shibuya K, Shimamura H, Sunamura M, Takeda K, Katoh H, Okada S, Suda K, Nakao A, Isaji S, Hiraoka T, Hosotani R, Imaizumi T. Pancreatic cancer current status of treatment and survival of 16071 patients diagnosed from 1981 to 1996, using the Japanese National Pancreatic Cancer Database. Int J Clin Oncol. 2000;5:153–7.CrossRef Matsuno S, Egawa S, Shibuya K, Shimamura H, Sunamura M, Takeda K, Katoh H, Okada S, Suda K, Nakao A, Isaji S, Hiraoka T, Hosotani R, Imaizumi T. Pancreatic cancer current status of treatment and survival of 16071 patients diagnosed from 1981 to 1996, using the Japanese National Pancreatic Cancer Database. Int J Clin Oncol. 2000;5:153–7.CrossRef
5.
go back to reference Egawa S, Takeda K, Fukuyama S, Motoi F, Sunamura M, Matsuno S. Clinicopathological aspects of small pancreatic cancer. Pancreas. 2004;28(3):235–40.CrossRefPubMed Egawa S, Takeda K, Fukuyama S, Motoi F, Sunamura M, Matsuno S. Clinicopathological aspects of small pancreatic cancer. Pancreas. 2004;28(3):235–40.CrossRefPubMed
6.
go back to reference Ariyama J, Suyama M, Satoh K, Sai J. Imaging of small pancreatic ductal adenocarcinoma. Pancreas. 1998;16(3):396–401.CrossRefPubMed Ariyama J, Suyama M, Satoh K, Sai J. Imaging of small pancreatic ductal adenocarcinoma. Pancreas. 1998;16(3):396–401.CrossRefPubMed
7.
8.
go back to reference Tsuchiya R, Noda T, Harada N, Miyamoto T, Tomioka T, Yamamoto K, Yamaguchi T, Izawa K, Tsunoda T, Yoshino R, et al. Collective review of small carcinomas of the pancreas. Ann Surg. 1986;203(1):77–81.CrossRefPubMedPubMedCentral Tsuchiya R, Noda T, Harada N, Miyamoto T, Tomioka T, Yamamoto K, Yamaguchi T, Izawa K, Tsunoda T, Yoshino R, et al. Collective review of small carcinomas of the pancreas. Ann Surg. 1986;203(1):77–81.CrossRefPubMedPubMedCentral
10.
go back to reference Muhi A, Ichikawa T, Motosugi U, Sou H, Nakajima H, Sano K, Sano M, Kato S, Kitamura T, Fatima Z, Fukushima K, Iino H, Mori Y, Fujii H, Araki T. Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI. Journal of magnetic resonance imaging: JMRI. 2011;34(2):326–35. doi:10.1002/jmri.22613.CrossRefPubMed Muhi A, Ichikawa T, Motosugi U, Sou H, Nakajima H, Sano K, Sano M, Kato S, Kitamura T, Fatima Z, Fukushima K, Iino H, Mori Y, Fujii H, Araki T. Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI. Journal of magnetic resonance imaging: JMRI. 2011;34(2):326–35. doi:10.​1002/​jmri.​22613.CrossRefPubMed
13.
go back to reference Semelka RC, Brown ED, Ascher SM, Patt RH, Bagley AS, Li W, Edelman RR, Shoenut JP, Brown JJ. Hepatic hemangiomas: a multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images. Radiology. 1994;192(2):401–6. doi:10.1148/radiology.192.2.8029404.CrossRefPubMed Semelka RC, Brown ED, Ascher SM, Patt RH, Bagley AS, Li W, Edelman RR, Shoenut JP, Brown JJ. Hepatic hemangiomas: a multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images. Radiology. 1994;192(2):401–6. doi:10.​1148/​radiology.​192.​2.​8029404.CrossRefPubMed
15.
go back to reference Roche CJ, Hughes ML, Garvey CJ, Campbell F, White DA, Jones L, Neoptolemos JP. CT and pathologic assessment of prospective nodal staging in patients with ductal adenocarcinoma of the head of the pancreas. AJR Am J Roentgenol. 2003;180(2):475–80. doi:10.2214/ajr.180.2.1800475.CrossRefPubMed Roche CJ, Hughes ML, Garvey CJ, Campbell F, White DA, Jones L, Neoptolemos JP. CT and pathologic assessment of prospective nodal staging in patients with ductal adenocarcinoma of the head of the pancreas. AJR Am J Roentgenol. 2003;180(2):475–80. doi:10.​2214/​ajr.​180.​2.​1800475.CrossRefPubMed
16.
go back to reference Nakamoto Y, Sakamoto S, Okada T, Senda M, Higashi T, Saga T, Togashi K. Clinical value of manual fusion of PET and CT images in patients with suspected recurrent colorectal cancer. AJR Am J Roentgenol. 2007;188(1):257–67. doi:10.2214/AJR.05.0708.CrossRefPubMed Nakamoto Y, Sakamoto S, Okada T, Senda M, Higashi T, Saga T, Togashi K. Clinical value of manual fusion of PET and CT images in patients with suspected recurrent colorectal cancer. AJR Am J Roentgenol. 2007;188(1):257–67. doi:10.​2214/​AJR.​05.​0708.CrossRefPubMed
17.
go back to reference Satoh Y, Ichikawa T, Motosugi U, Kimura K, Sou H, Sano K, Araki T. Diagnosis of peritoneal dissemination: comparison of 18F-FDG PET/CT, diffusion-weighted MRI, and contrast-enhanced MDCT. AJR Am J Roentgenol. 2011;196(2):447–53. doi:10.2214/AJR.10.4687.CrossRefPubMed Satoh Y, Ichikawa T, Motosugi U, Kimura K, Sou H, Sano K, Araki T. Diagnosis of peritoneal dissemination: comparison of 18F-FDG PET/CT, diffusion-weighted MRI, and contrast-enhanced MDCT. AJR Am J Roentgenol. 2011;196(2):447–53. doi:10.​2214/​AJR.​10.​4687.CrossRefPubMed
20.
go back to reference Evangelista L, Panunzio A, Polverosi R, Pomerri F, Rubello D. Indeterminate lung nodules in cancer patients: pretest probability of malignancy and the role of 18F-FDG PET/CT. AJR Am J Roentgenol. 2014;202(3):507–14. doi:10.2214/AJR.13.11728.CrossRefPubMed Evangelista L, Panunzio A, Polverosi R, Pomerri F, Rubello D. Indeterminate lung nodules in cancer patients: pretest probability of malignancy and the role of 18F-FDG PET/CT. AJR Am J Roentgenol. 2014;202(3):507–14. doi:10.​2214/​AJR.​13.​11728.CrossRefPubMed
23.
go back to reference Bilimoria KY, Bentrem DJ, Ko CY, Ritchey J, Stewart AK, Winchester DP, Talamonti MS. Validation of the 6th edition AJCC pancreatic cancer staging system: report from the National Cancer Database. Cancer. 2007;110(4):738–44. doi:10.1002/cncr.22852.CrossRefPubMed Bilimoria KY, Bentrem DJ, Ko CY, Ritchey J, Stewart AK, Winchester DP, Talamonti MS. Validation of the 6th edition AJCC pancreatic cancer staging system: report from the National Cancer Database. Cancer. 2007;110(4):738–44. doi:10.​1002/​cncr.​22852.CrossRefPubMed
24.
25.
go back to reference Kim JH, Park SH, ES Y, Kim MH, Kim J, Byun JH, Lee SS, Hwang HJ, Hwang JY, Lee MG. Visually isoattenuating pancreatic adenocarcinoma at dynamic-enhanced CT: frequency, clinical and pathologic characteristics, and diagnosis at imaging examinations. Radiology. 2010;257(1):87–96. doi:10.1148/radiol.10100015.CrossRefPubMed Kim JH, Park SH, ES Y, Kim MH, Kim J, Byun JH, Lee SS, Hwang HJ, Hwang JY, Lee MG. Visually isoattenuating pancreatic adenocarcinoma at dynamic-enhanced CT: frequency, clinical and pathologic characteristics, and diagnosis at imaging examinations. Radiology. 2010;257(1):87–96. doi:10.​1148/​radiol.​10100015.CrossRefPubMed
Metadata
Title
Time to Progression of Pancreatic Cancer: Evaluation with Multi-Detector Computed Tomography
Authors
Su Joa Ahn
Seung Joon Choi
Hyung Sik Kim
Publication date
01-06-2017
Publisher
Springer US
Published in
Journal of Gastrointestinal Cancer / Issue 2/2017
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-016-9876-7

Other articles of this Issue 2/2017

Journal of Gastrointestinal Cancer 2/2017 Go to the issue